Beth Hecht
CIK: 0001652410
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xeris Biopharma Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Oct 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $9.41$157K - Sep 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $8.49$141K - Aug 3, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $8.01$134K - Jul 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $8.03$134K - Jun 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $6.06$101K - May 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $6.23$104K - Apr 1, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $5.99$100K - Mar 2, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.6K shares at avg. $6.24$103K - Mar 2, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct100 shares at avg. $7.06$706 - Feb 2, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $7.45$124K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct98.4K shares at avg. $7.36$724K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct24.3K shares at avg. $7.36$179K - Jan 31, 2026XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct46.9K shares at avg. $7.36$345K - Jan 30, 2026XERS
Xeris Biopharma Holdings, Inc.
Award(A)Direct121.3K shares- - Jan 2, 2026XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $7.43$124K - Dec 1, 2025XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $7.01$117K - Nov 11, 2025XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct16.7K shares at avg. $7.40$123K - Mar 20, 2025XERS
Xeris Biopharma Holdings, Inc.
Sale(S)Direct40K shares at avg. $5.43$217K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Award(A)Direct185K shares- - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct45.9K shares at avg. $3.56$163K - Jan 31, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct98.4K shares at avg. $3.56$350K - Jan 3, 2025XERS
Xeris Biopharma Holdings, Inc.
Tax Payment(F)Direct32K shares at avg. $3.61$116K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,666 | $9.41 | $156,792 | Direct |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,666 | $8.49 | $141,434 | Direct |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,666 | $8.01 | $133,553 | Direct |
| Jul 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,666 | $8.03 | $133,860 | Direct |
| Jun 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $6.06 | $100,982 | Direct |
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $6.23 | $103,805 | Direct |
| Apr 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $5.99 | $99,859 | Direct |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,567 | $6.24 | $103,380 | Direct |
| Mar 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 100 | $7.06 | $706 | Direct |
| Feb 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $7.45 | $124,147 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 98,375 | $7.36 | $724,040 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 24,266 | $7.36 | $178,598 | Direct |
| Jan 31, 2026 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 46,914 | $7.36 | $345,287 | Direct |
| Jan 30, 2026 | XERS Xeris Biopharma Holdings, Inc. | Award(A) | 121,293 | - | $0 | Direct |
| Jan 2, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $7.43 | $123,776 | Direct |
| Dec 1, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $7.01 | $116,781 | Direct |
| Nov 11, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 16,667 | $7.40 | $123,296 | Direct |
| Mar 20, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale(S) | 40,000 | $5.43 | $217,244 | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Award(A) | 185,000 | - | - | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 45,909 | $3.56 | $163,436 | Direct |
| Jan 31, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 98,375 | $3.56 | $350,215 | Direct |
| Jan 3, 2025 | XERS Xeris Biopharma Holdings, Inc. | Tax Payment(F) | 32,039 | $3.61 | $115,661 | Direct |
1-22 of 22 transactions
About Hecht Beth
Hecht Beth (SEC CIK 0001652410) files insider reports with the SEC as Officer of Xeris Biopharma Holdings, Inc. (XERS).
Signal8 holds 15 ownership filings by Hecht Beth, all Form 4s, filed between Jan 7, 2025 and Oct 2, 2026. Those filings report 22 transactions, from Jan 3, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hecht Beth's filings is in CHICAGO, IL.
Recent filings by Hecht Beth
- Oct 1, 2026: Open-market sale of XERS shares (Form 4, code S).
- Sep 1, 2026: Open-market sale of XERS shares (Form 4, code S).
- Aug 3, 2026: Open-market sale of XERS shares (Form 4, code S).
- Jul 1, 2026: Open-market sale of XERS shares (Form 4, code S).
- Jun 1, 2026: Open-market sale of XERS shares (Form 4, code S).
Other insiders filing for Xeris Biopharma Holdings, Inc. (XERS)
- Pieper Steven
- McCulloch Kevin
- Shannon John Patrick Jr
- KREHER NERISSA, Director
- Kong Garheng, Director
- PERSKY MARLA, Director